CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases

• Published in: Frontiers in medicine Vol. 10; p. 1152587
• Main Authors: Chevalier, Kevin, Genin, Michaël, Jean, Thomas Petit, Avouac, Jerôme, Flipo, Rene-Marc, Georgin-Lavialle, Sophie, El Mahou, Soumaya, Pertuiset, Edouard, Pham, Thao, Servettaz, Amelie, Marotte, Hubert, Domont, Fanny, Chazerain, Pascal, Devaux, Mathilde, Mekinian, Arsene, Sellam, Jérémie, Fautrel, Bruno, Rouzaud, Diane, Ebstein, Esther, Costedoat-Chalumeau, Nathalie, Richez, Christophe, Hachulla, Eric, Mariette, Xavier, Seror, Raphaèle
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers media 22.03.2023; Frontiers Media S.A
• Subjects: auto-immune diseases; COVID-19; inflammatory rheumatic diseases; Life Sciences; lupus; Medicine; rituximab; vasculitis; COVID-19; inflammatory rheumatic diseases; vasculitis; lupus; rheumatic and musculoskeletal diseases; auto-immune diseases; rituximab

Autoimmune/inflammatory rheumatic diseases (AIRDs) patients might be at-risk of severe COVID-19. However, whether this is linked to the disease or to its treatment is difficult to determine. This study aimed to identify factors associated with occurrence of severe COVID-19 in AIRD patients and to ev...